title: [Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal].
authors.affiliation: Jenapharm GmbH, Bereich Forschung und Entwicklung Jena, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Dittgen
authors.forename: H
authors.initials: H
authors.lastname: Zimmermann
authors.forename: W
authors.initials: W
authors.lastname: Wober
authors.forename: C
authors.initials: C
authors.lastname: Höflich
authors.forename: H
authors.initials: H
authors.lastname: Breitbarth
authors.forename: C
authors.initials: C
authors.lastname: Timpe
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001682:Biological Availability; D018592:Cross-Over Studies; D004304:Dosage Forms; D004928:Escin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D006207:Half-Life; D006801:Humans; D008297:Male; D011863:Radioimmunoassay
chemical_list: D004304:Dosage Forms; D004928:Escin
vernacular_title: Untersuchung der Bioverfügbarkeit von beta-Aescin nach oraler Verabreichung verschiedener Darreichungsformen. Kommentar zu den Ergebnissen von Kunz et al. sowie Schrader et al., publiziert in dieser Zeitschrift.